IM Cannabis Signs Definitive Deal to Sell European Assets, Boosting Equity by C$3M
IMCC sits 27% above its 52-week low of $0.097 on light trading volume (0.1× avg).
Summary
IM Cannabis has converted its June 18 non-binding letter of intent into a definitive share purchase agreement to sell IMC Holdings and its European-focused assets to Slil.com Holding Ltd., an entity controlled by CEO Oren Shuster. The consideration consists of prior aggregate C$3 million advance payments made by Slil, plus Slil's assumption of retained liabilities not to exceed C$9.4 million in the aggregate unless otherwise adjusted by mutual agreement. The deal is expected to improve shareholders' equity by approximately C$3 million and reduce liabilities. The company will retain its Israeli medical cannabis operations. Closing is subject to customary conditions and an outside date of September 30, 2026.
At the time of this announcement, IMCC was trading at $0.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $0.10 to $2.83. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.